iglarlixi

Showing 2 posts of 2 posts found.

Sanofi reveals promising data for FDA-delayed diabetes drug

September 14, 2016
Research and Development, Sales and Marketing FDA, Lantus, Sanofi, iglarlixi

Sanofi has announced new Phase III data for its IGlarLixi combination drug for the treatment of diabetes, showing it could …

FDA delays appraisal of Sanofi, Zealand diabetes drug just days before decision due

August 22, 2016
Research and Development, Sales and Marketing NDA, Sanofi, appraisal, diabetes, iglarlixi, type 2, type-2, zealand

There was unfortunate news for Sanofi and Zealand Pharma as the FDA announced that it required additional information, constituting a …

The Gateway to Local Adoption Series

Latest content